Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Intravenous Cefazolin Plus Oral Probenecid With Oral Cephalexin for the Treatment of Cellulitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients presenting to the emergency department with a presumed diagnosis of mild to moderate skin and soft tissue infection~* Deemed well enough to be treated as an outpatient~* 19 years of age or older~Exclusion Criteria:~* known allergy to study drugs~* known chronic kidney disease with a creatinine clearance \<30 mL/min~* known previous methicillin-resistant staphylococcus aureus (MRSA) infection~* use of antibiotics for greater than 24 hours in the past 7 days~* wound/abscess requiring operative debridement or incision and drainage~* suspected necrotizing fasciitis, osteomyelitis or septic arthritis~* febrile neutropenia~* concomitant documented bacteremia~* Two or more signs of systemic sepsis~* new altered mental status~* infections at a site involving prosthetic materials~* animal or human bite wound infections~* post-operative wound infections~* known peripheral vascular disease~* superficial thrombophlebitis~* pregnant/breastfeeding~* obesity (BMI \> 30 kg/m2)

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- IV cefazolin plus oral probenecid and placebo cephalexin (Type: ACTIVE_COMPARATOR): None
- Oral cephalexin and saline IV plus probenecid placebo (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).